Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
filingDate |
2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16f8fdd8be5954a2b9d13c92a7ca98f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a33e210c33f58b78d1d5a2cb3d660a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc629b2287551ad28f725117cfce7ec3 |
publicationDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20100134699-A |
titleOfInvention |
Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NSC5 Inhibitors |
abstract |
The present disclosure provides compounds of Formula I and salts thereof, and compositions and methods of using the compounds. The compounds are active against hepatitis C virus (HCV) and are useful for the treatment of those infected with HCV. |
priorityDate |
2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |